Overview
Employees
11-50
Total raised
$40M
Founded date
2007
Funding Rounds 2
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| May 11, 2010 | Funding round | $10M |
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 19, 2014 | N30 Pharmaceuticals Raises $30M in Mezzanine Financing | N30 Pharmaceuticals, Inc., a Boulder, Colorado-based biopharmaceutical company focused on the development of therapies for cystic fibrosis (CF), raised $30m in mezzanine financing. Backers included new investors Wellington Management, RA Ca... |
| May 11, 2010 | N30 Pharma Completes $10M Financing | N30 Pharma, a Boulder, Colorado-based biopharmaceutical company focused on developing s-nitrosothiol (SNO)-based therapies for major unmet needs in respiratory, cardiovascular, and inflammatory diseases, has completed a $10m financing. In c... |
Reviews 0
FAQ about N30 Pharmaceuticals
When was N30 Pharmaceuticals founded?
N30 Pharmaceuticals was founded in 2007.
How much funding has N30 Pharmaceuticals raised?
N30 Pharmaceuticals has raised $40M in total across 2 funding rounds.
What funding rounds has N30 Pharmaceuticals raised?
Parsers VC lists 2 funding rounds of N30 Pharmaceuticals, among them a funding round of $10M on May 11, 2010.
What has the press written about N30 Pharmaceuticals?
Parsers VC has collected 3 articles mentioning N30 Pharmaceuticals, among them “N30 Pharmaceuticals Raises $30M in Mezzanine Financing” (Nov 19, 2014) and “N30 Pharma Completes $10M Financing” (May 11, 2010).
Is N30 Pharmaceuticals still active?
Yes, N30 Pharmaceuticals is active; its latest activity on Parsers VC dates from Nov 21, 2014.